7-Dehydrodesmosterol

From WikiMD's WELLNESSPEDIA

7-Dehydrodesmosterol is a sterol intermediate in the biosynthesis of cholesterol. It is a crucial compound in the mevalonate pathway, which is the metabolic pathway that produces isoprenoids, including cholesterol and other sterols. Understanding the role of 7-Dehydrodesmosterol is important for comprehending the complex processes involved in cholesterol synthesis and regulation.

Structure and Properties[edit]

7-Dehydrodesmosterol is a sterol with the chemical formula C27H42O. It is characterized by a double bond in the sterol ring structure, which is a common feature in sterol intermediates. The presence of this double bond distinguishes it from other sterols such as desmosterol and cholesterol.

Biosynthesis[edit]

7-Dehydrodesmosterol is synthesized from lanosterol through a series of enzymatic reactions. The conversion involves multiple steps, including the removal of methyl groups and the introduction of double bonds. This process is part of the larger mevalonate pathway, which is responsible for the production of cholesterol and other essential sterols.

Biological Role[edit]

In the body, 7-Dehydrodesmosterol serves as a precursor to cholesterol. Cholesterol is a vital component of cell membranes, where it modulates fluidity and permeability. It is also a precursor for the synthesis of steroid hormones, bile acids, and vitamin D. The regulation of cholesterol synthesis, including the conversion of 7-Dehydrodesmosterol, is tightly controlled by feedback mechanisms to maintain homeostasis.

Clinical Significance[edit]

Abnormalities in the metabolism of 7-Dehydrodesmosterol can lead to disorders in cholesterol synthesis. For example, defects in the enzymes involved in its conversion can result in conditions such as desmosterolosis, a rare genetic disorder characterized by elevated levels of desmosterol and related sterol intermediates. Understanding these pathways is crucial for developing treatments for such metabolic disorders.

Also see[edit]

Template:Cholesterol biosynthesis Template:Sterol metabolism

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.